About – Rametrix® Technology, Inc.

WHO WE ARE

What is Rametrix® Technologies, Inc. Hoping to Accomplish?

Rametrix® Technologies, Inc. is dedicated to improving human and animal health and quality of life – through engineering and scientific research and translation from “bench to bedside” through clinical studies. We value and embrace rigorous, exhaustive, and independent review of our research productivity that is demonstrated in peer-reviewed publications and meaningful independent oversight by our Medical and Business Advisory Board. Our passions are productivity and progress.

SOME FACTS

Providing Meaningful Results for Healthcare Decision-Making

EARLIER, FASTER, CHEAPER DISEASE SCREENING

Rametrix® Technologies, Inc. proprietary tests and analytics provide early indicators specific for a given disease so doctors & patients can proactively manage disease with the objective of limiting disease progression

DISEASE SCREENING SOLUTION

Urine Sample – Computational Analysis – Early Screening
Provides a unique multi-molecular Diagnostic Enrichment Biomarkers signature for improving medical diagnostics and reducing the need for (and number of ) more invasive or expensive procedures (tissue biopsies) that many physicians try to avoid

INEXPENSIVE

Inexpensive: <$25/analysis and reimbursable; direct cost <$1/analysis

CORE VALUES

Personal and Organizational Integrity

A Dedication to Excellence

Trust and Transparency in Interpersonal and Business Dealings

Unrelenting Persistence in Overcoming the Challenges of Disease and Improving Lives

OUR RESULTS

Published Results From Analysis of More Than 3000 Specimens

patent applications

provisional patent submissions

papers co-authored with experts

WE ARE Rametrix® Technologies, Inc.

Every molecular fingerprint matters!

Our Testimonials

I have had an evolving interest in Rametrix® Technologies, Inc. since teaming up with Drs. Robertson and Senger several years ago, in my role as a renal clinician, to study the use of Raman spectral analyses of waste dialysate in end stage kidney disease patients in order to determine the optimal dose of hemodialysis. Since that initial study, I have continued to witness, as both co-investigator and ‘spectator,’ the power of the Rametrix® Technologies, Inc. process in identifying characteristic and often unique molecular patterns in the urine of patients with various renal diseases, I have come to believe that this technology has a great deal of potential for both the diagnosis and management of patients with an array of urinary tract disorders.

Allan H Sklar

Board Member

The application of technology to the improvement of the human condition is a remarkable and worthwhile endeavor and Rametrix® Technologies, Inc. is poised to leave its mark on the healthcare industry.

Mike Abbott

Board Member

I consider the Rametrix® Technologies, Inc. technology a unique opportunity to provide rapid and accurate results to solve a series of significant technical and medical problems. I am very pleased to assist with marketing issues for a company with extraordinary potential.

Jeffrey Hoffman

Marketing Consultant

In my career, I have worked with hundreds of medical device and drug companies. Rametrix® Technologies, Inc. is a member of an incredibly rare breed with a technology that already is shown to be clinically effective at such an early stage of the company. The excellent research by Dr. Robertson and Dr. Senger. based on the exceptionally good quality data from the VA system. that includes hundreds of samples with biopsy-confirmed diagnoses, full demographic information, and detailed health history is almost unheard of for a company this size. As a former public health official, I can’t stress enough the importance of introducing this technology to medical practice so it can help US patients.

Mehmet Kosoglu

Regulatory Advisor